USPTO serial 97052734
STENTIT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 11, 2023
- Examiner
- HERRERA-MARCUS, ROSELLE MORALDE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with STENTIT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Eindhoven, NL
Eindhoven, NL
Eindhoven, NL
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
B. Anna McCoy
B. Anna McCoy MCCOY RUSSELL LLP1410 NW JOHNSON STREETSUITE 201PORTLAND, OR 97209Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Coronary artery bypass grafts; Surgical implants comprising living tissue; Biological implants, namely, endovascular implants; Implants for guided tissue regeneration; Implantable materials for use in guided tissue regeneration; Implantable textile material to encourage the growth of tissue; Arterial grafts; Vascular grafts; Skin grafts; Adhesive patches for medical purposes; Transdermal patches for medical treatment for use in the treatment of vascular constriction; Tissue-regenerative pharmaceutical preparations; Biological tissue for medical use; Biological tissue for surgical use; Live organs and tissues for surgical purpose | ACTIVE | — |
| 010 | Angioplasty catheters; Angioplasty balloon catheters; Angiographic vascular introducers for the placement of catheters; Balloon angioplasty inflation instruments; Balloon angioplasty inflation apparatus; Balloon catheters; Balloon inflating devices for balloon dilation catheters; Calibration catheters; Cannulae; Cardiac catheters; Cardiac vascular prosthesis for surgical protheses; Cardiovascular instruments; Catheter apparatus for gastroenterological use; Catheter sets; Catheters; Catheters for medical use; Catheters for surgical use; Catheters for urological purposes; Catheters for use in urology; Catheters for use in embolectomy; Catheters incorporating filters; Central venous catheters; Cervical balloon catheters; Cervical portio adapters; Chest drainage devices for removal of fluids from the pleural cavity of patients; Coronary balloon dilatation catheters for angioplasty; Dilatation catheters; Embolic devices; Endotracheal tubes; Expandable braids for insertion in tubular organs of the body for the treatment of stenosis; Expandable braids for insertion in oesophagus for the treatment of stenosis; Expandable braids for insertion in blood vessels for treating stenosis; Expandable braids for insertion in bile ducts for treating stenosis; Filters for use within veins; Filters for temporary placement within veins; Guide wires for use with balloon dilation catheters; Guide wires for use with balloon dilatation catheters; Medical Guidewires; Injection sleeves for medical use; Inner lumens for balloon catheters; Instruments for intraluminar sclerosation of varicose veins; Intracardiac catheter; Intramedullary plugs; Intravenous catheter sets; Intravenous catheters; Instruments for use in gastrointestinal surgery; Introducers for implanting vena-cava filters; Introducers for implanting anti-embolic filters; Medical and surgical catheters; Medical apparatus for urethral catheterization; Medical apparatus for use in cardiac surgery; Medical apparatus for use in endoscopy; Medical catheters; Medical devices for placing and securing catheters; Medical guidewires; Medical tubing for transfusions; Mesh nerve connecting tubes for medical use; Protective guards for catheters; Shunts for use in the blood circulatory system; Surgical bypass devices; Surgical mesh comprised primarily of artificial materials; Tubing for use with catheters; Tubing for use with cannulas; Tubes for veterinary use, namely, fibrous polymer tubes; Urethral catheterization instruments; Urethral catheters; Venous catheters for human use; Vascular access ports for medical use; Medical devices for closing wounds; Wound closures, namely, sutures, surgical staples, closure tapes, and adhesives; Medical stents; Implantable urethral stents; Ureteral stents being surgical support; Biocompatible coated stents; Stents; Surgical apparatus and instruments for medical use; Artificial surgical implants; Surgical implants comprising artificial material; Surgical implants comprised of artificial materials; Surgical implants made of artificial materials; Prosthetic implants; Biodegradable implants, namely, biodegradable stents; Artificial implants; Implants; Medical implants comprised of artificial materials; Artificial organs and implants; Prosthetics and artificial implants; Subcutaneous valves for implantation comprised of artificial materials; Implants consisting of artificial materials; Medical implants made of artificial materials; Medical devices, namely, intravascular implants comprised of artificial material; Subcutaneous valves comprised of artificial materials for implantation; Artificial vascular grafts; Synthetic Grafts for surgical use; Medical devices, namely, fibrous medical devices; Medical and veterinary apparatus and instruments, namely, stents for the treatment of cardiovascular diseases; Sutures; Suture and wound closing materials and products, namely, surgical steel, silk, linen, nylon, polypropylene, polybutester, coton, surgical gut, polyglycolic acid, polyglactin 910, polydioxanone, polytrimethylene carbonate, glycomer 631, polyglytone 6211 poliglecaprone; Prosthetic tissues for vascular use | ACTIVE | — |
| 042 | Tissue engineering; Science and technology services, namely, regenerative tissue engineering and regenerative medical devices; Medical and pharmacological research services; Engineering services, namely, engineering for medical devices; Testing, authentication and quality control of medical devices; Research services, namely, regenerative medicine, medical devices; Quality control for others; Material Testing | ACTIVE | — |
| 044 | Medical care; Medical treatment of aneurysms, atherosclerosis, cardiovascular diseases, coronary heart disease, lymphatic diseases, vasoconstriction, stroke, myocardial infarction, lymphatic diseases, diseases of the urinary tract, stenosis, Medical services; Professional consultancy relating to Veterinary services; Veterinary surgery; Veterinary services; Hygienic and beauty care for animals; Hygienic and beauty care for human beings; Pharmaceutical advice; Medical assistance; Hospital services; Health care; Health centers services; Medical clinic services; Telemedicine services; Therapy services, namely, revascularizing therapy; Medical equipment rental | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Stentit BV
- Other trademarks owned by Stentit BV
- Other trademarks owned by Stentit BV
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named STENTIT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 27, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 27, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 27, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 11, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 11, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 24, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 24, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 4, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 21, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Dec 16, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Dec 8, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 8, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 7, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 7, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 30, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 30, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 30, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 28, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 28, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 2, 2021 | NWAP | NEW APPLICATION ENTERED | — |